92 related articles for article (PubMed ID: 1996632)
1. Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans.
Druml W; Lochs H; Roth E; Hübl W; Balcke P; Lenz K
Am J Physiol; 1991 Feb; 260(2 Pt 1):E280-5. PubMed ID: 1996632
[TBL] [Abstract][Full Text] [Related]
2. Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure.
Druml W; Hübl W; Roth E; Lochs H
Hepatology; 1995 Apr; 21(4):923-8. PubMed ID: 7705801
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source.
Druml W; Roth E; Lenz K; Lochs H; Kopsa H
Kidney Int Suppl; 1989 Nov; 27():S282-6. PubMed ID: 2517676
[TBL] [Abstract][Full Text] [Related]
4. Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man.
Hübl W; Druml W; Roth E; Lochs H
Metabolism; 1994 Sep; 43(9):1104-7. PubMed ID: 8084285
[TBL] [Abstract][Full Text] [Related]
5. Influence of molecular structure on half-life and hydrolysis of dipeptides in plasma: importance of glycine as N-terminal amino acid residue.
Adibi SA; Paleos GA; Morse EL
Metabolism; 1986 Sep; 35(9):830-6. PubMed ID: 3747839
[TBL] [Abstract][Full Text] [Related]
6. Elimination of amino acids in chronic renal failure.
Druml W; Kleinberger G; Bürger U; Balcke P; Laggner A; Lenz K; Schmidt P; Zazgornik J
Infusionsther Klin Ernahr; 1986 Dec; 13(6):262-7. PubMed ID: 3102371
[TBL] [Abstract][Full Text] [Related]
7. Availability of amino acids supplied by constant intravenous infusion of synthetic dipeptides in healthy man.
Albers S; Wernerman J; Stehle P; Vinnars E; Fürst P
Clin Sci (Lond); 1989 Jun; 76(6):643-8. PubMed ID: 2736882
[TBL] [Abstract][Full Text] [Related]
8. Influence of molecular structure and plasma hydrolysis on the metabolism of glutamine-containing dipeptides in humans.
Hübl W; Druml W; Langer K; Lochs H
Metabolism; 1989 Aug; 38(8 Suppl 1):59-62. PubMed ID: 2761422
[TBL] [Abstract][Full Text] [Related]
9. Stress-induced intracellular glutamine depletion. The potential use of glutamine-containing peptides in parenteral nutrition.
Fürst P; Albers S; Stehle P
Beitr Infusionther Klin Ernahr; 1987; 17():117-36. PubMed ID: 3120690
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of hepatic assimilation of dipeptides. Transport versus hydrolysis.
Lochs H; Morse EL; Adibi SA
J Biol Chem; 1986 Nov; 261(32):14976-81. PubMed ID: 3533928
[TBL] [Abstract][Full Text] [Related]
12. A concentrated mixture of amino acids and dipeptides for total parenteral nutrition.
Vazquez JA; Paleos GA; Lochs H; Langer K; Brandl M; Adibi SA
Infusionsther Klin Ernahr; 1986 Aug; 13(4):193-8. PubMed ID: 3093380
[TBL] [Abstract][Full Text] [Related]
13. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
14. Elimination of amino acids in renal failure.
Druml W; Fischer M; Liebisch B; Lenz K; Roth E
Am J Clin Nutr; 1994 Sep; 60(3):418-23. PubMed ID: 8074076
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and of malnutrition.
Schmid G; Bahner U; Peschkes J; Heidland A
Miner Electrolyte Metab; 1996; 22(1-3):115-8. PubMed ID: 8676800
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
18. Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions.
Weryński A; Waniewski J; Wang T; Anderstam B; Lindholm B; Bergström J
Kidney Int; 2001 Jan; 59(1):363-71. PubMed ID: 11135092
[TBL] [Abstract][Full Text] [Related]
19. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
